Base · 58 · Common · 1999
Showing the First Edition Shadowless Red Cheeks printing: its own raw price and its own graded prices. The population report is the card's — no source publishes one per printing.
The raw price over time, with any graded series laid over the same axis — the comparison a grading decision turns on.
No price history yet.
The raw line is TCGplayer's quoted market price, recorded daily; One Piece and Riftbound carry PriceCharting's monthly level instead. Neither is a record of sales. This card has no series yet — either it sits outside the enrichment budget, or the one found disagreed with the price above and was dropped rather than shown.
Every graded price published, next to how many copies exist at that grade.
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| PSA 10 | $28,908 | 67.2× | — | — |
| PSA 9 | $2,607 | 6.1× | — | — |
| PSA 8 | $1,204 | 2.8× | — | — |
| PSA 7 | $996 | 2.3× | — | — |
| PSA 6 | $770 | 1.8× | — | — |
| PSA 5 | $607 | 1.4× | — | — |
| PSA 4 | $578 | 1.3× | — | — |
| PSA 3 | $484 | 1.1× | — | — |
| PSA 2 | $512 | 1.2× | — | — |
| PSA 1 | $845 | 2.0× | — | — |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| BGS 9.5 | $4,880 | 11.3× | — | — |
| BGS 9 | $1,000 | 2.3× | — | — |
| BGS 8.5 | $1,154 | 2.7× | — | — |
| BGS 7.5 | $602 | 1.4× | — | — |
| BGS 7 | $710 | 1.7× | — | — |
| BGS 5 | $360 | 0.8× | — | — |
| BGS 3.5 | $264 | 0.6× | — | — |
| BGS 3 | $256 | 0.6× | — | — |
| Grade | Market | vs raw | Population | Pop higher |
|---|---|---|---|---|
| CGC 10 | $5,217 | 12.1× | — | — |
| CGC 9.5 | $30.00 | 0.1× | — | — |
| CGC 9 | $1,894 | 4.4× | — | — |
| CGC 8.5 | $1,077 | 2.5× | — | — |
| CGC 8 | $851 | 2.0× | — | — |
| CGC 7.5 | $750 | 1.7× | — | — |
| CGC 7 | $665 | 1.5× | — | — |
| CGC 6.5 | $599 | 1.4× | — | — |
| CGC 6 | $408 | 0.9× | — | — |
| CGC 5 | $476 | 1.1× | — | — |
| CGC 4.5 | $400 | 0.9× | — | — |
| CGC 4 | $400 | 0.9× | — | — |
| CGC 3.5 | $299 | 0.7× | — | — |
| CGC 2 | $25.00 | 0.1× | — | — |
A model's opinion, not investment advice.